Veterinary Psychopharmacology

 
 
Standards Information Network (Verlag)
  • 2. Auflage
  • |
  • erschienen am 3. Januar 2019
  • |
  • 336 Seiten
 
E-Book | PDF mit Adobe-DRM | Systemvoraussetzungen
978-1-119-22624-6 (ISBN)
 
Offers an updated second edition of the comprehensive reference on the use of drugs for veterinary mental health care and behavior modification

This fully revised Second Edition of Veterinary Psychopharmacology offers an authoritative reference to the drugs prescribed to treat psychiatric, psychological, and behavioral disorders in pets. Designed to be an accessible resource, the text is divided into sections on psychopharmacologic principles and clinical psychopharmacology. Comprehensive in scope, the book contains detailed information on pharmacologic intervention for pet mental health and behavior issues, offers thorough explanations of options, and explores why a particular drug should be prescribed and why it works.

Updated to include the recent advances in psychopharmacology for pets, the Second Edition includes new chapters that cover the principles of psychopharmacology, miscellaneous serotonergic agents, anticonvulsants and mood stabilizers, sympatholytic agents, and NMDA antagonists. In addition, the text explains the drug options, including all the information necessary to correct dysfunctions in the brain's chemistry through pharmacologic treatment. This important resource:
* Presents an updated and comprehensive resource for pharmacologic treatments for pet, equine, and zoo animal psychiatric disorders and behavior problems
* Contains in-depth information on drugs that promote neurochemical changes that will alter the mood, emotional state, reactivity, and behavior of the patient, including prescribing options and mechanisms of action
* Includes new chapters on the principles of psychopharmacology, miscellaneous serotonergic agents, mood stabilizers, sympatholytic agents, and NMDA antagonists

Written for veterinarians, veterinary behaviorists, and veterinary students, the updated second edition of Veterinary Psychopharmacology is a complete source for current knowledge on pharmacologic behavior modification.

"Overall, this book packs a substantial amount of useful data into approximately 300 pages. The scope of the book is comprehensive and may include more in-depth information than casual prescribers seek, but it will be a good resource for the practitioners who are interested in immersing themselves into veterinary psychopharmacology." - JAVMA Vol 255 No. 6
2. Auflage
  • Englisch
  • Newark
  • |
  • USA
John Wiley & Sons Inc
  • Für Beruf und Forschung
  • |
  • Für höhere Schule und Studium
  • Überarbeitete Ausgabe
  • 5,77 MB
978-1-119-22624-6 (9781119226246)
weitere Ausgaben werden ermittelt
The Authors

The Editors

Sharon L. Crowell-Davis, DVM, PhD, DACVB, is a Professor of Behavioral Medicine in the Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, the University of Georgia in Athens, Georgia, USA.

Thomas F. Murray, PhD, is a Professor of Pharmacology and Provost of Creighton University in Omaha, Nebraska, USA.

Leticia Mattos de Souza Dantas, DVM, MS, PhD, DACVB is a Clinical Assistant Professor of Behavioral Medicine at the University of Georgia Veterinary Teaching Hospital and the Department of Veterinary Biosciences and Diagnostic Imaging at the College of Veterinary Medicine, University of Georgia in Athens, Georgia, USA. She is also the Director and Co-founder of ZooPsych, Inc., a consultancy in Clinical Behavioral Medicine & Therapy in Georgia, USA.
  • Intro
  • Title Page
  • Copyright Page
  • Contents
  • Contributors
  • Preface
  • Acknowledgments
  • Part I Principles of Veterinary Psychopharmacology
  • Chapter 1 General Principles of Psychopharmacology
  • Drug Action
  • Dose Dependence of Drug Interaction with Receptors
  • Structural Features of the Central Nervous System (CNS) and Neurotransmission
  • Biogenic Amine Neurotransmitters and Affective Disorders
  • References
  • Chapter 2 Amino Acid Neurotransmitters: Glutamate, GABA, and the Pharmacology of Benzodiazepines
  • Introduction
  • Glutamatergic Synapses
  • Pharmacology of Ketamine and Tiletamine
  • GABAergic Synapses
  • References
  • Chapter 3 Biogenic Amine Neurotransmitters: Serotonin
  • Introduction
  • The Biogenic Amines
  • Serotonin
  • References
  • Chapter 4 Biogenic Amine Transmitters: Acetylcholine, Norepinephrine, and Dopamine
  • Acetylcholine
  • Norepinephrine
  • Dopamine
  • References
  • Chapter 5 Neuropeptides: Opioids and Oxytocin
  • Introduction
  • Endogenous Opioid Peptides
  • Oxytocin
  • References
  • Part II Practice of Veterinary Psychopharmacology
  • Chapter 6 Introduction to Clinical Psychopharmacology for Veterinary Medicine
  • Introduction
  • Prescribing in the United States: The Animal Medicinal Drug Use Clarification Act (AMDUCA 1994)
  • Cost
  • Drug Selection
  • Medicating the Patient
  • Competition Animals
  • Taking the Behavioral History
  • The Behavioral Exam
  • Duration of Treatment
  • Limitations
  • References
  • Chapter 7 Benzodiazepines
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Overdose
  • Clinical Guidelines
  • Specific Medications
  • I. Alprazolam
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • II. Chlordiazepoxide HC1
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • III. Clonazepam
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Drug Interactions
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • IV. Clorazepate Dipotassium
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Dependence
  • Overdose
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • V. Diazepam
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Other
  • Effects Documented in Nonhuman Animals
  • VI. Flurazepam Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • VII. Lorazepam
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Effects Documented in Nonhuman Animals
  • VIII. Oxazepam
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • IX. Triazolam
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • Important Information for Owners of Pets Being Placed on Any Benzodiazepine
  • References
  • Chapter 8 Selective Serotonin Reuptake Inhibitors
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Adverse Drug Interactions
  • Overdose
  • Clinical Guidelines
  • Specific Medications
  • I. Citalopram Hydrobromide
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Other Information
  • Effects Documented in Nonhuman Animals
  • II. Fluoxetine Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation of Fluoxetine
  • Other Information
  • Effects Documented in Nonhuman Animals
  • III. Fluvoxamine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Other Information
  • Effects Documented in Nonhuman Animals
  • IV. Paroxetine Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation of Paroxetine
  • Other Information
  • Effects Documented in Nonhuman Animals
  • V. Sertraline Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Other Information
  • Effects Documented in Nonhuman Animals
  • VI. Escitalopram Oxalate
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Other Information
  • Effects Documented in Nonhuman Animals
  • Important Information for Owners of Pets Being Placed on Any SSRI
  • References
  • Chapter 9 Miscellaneous Serotonergic Agents
  • Introduction
  • Azapirones
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Adverse Drug Interactions
  • Overdose
  • Clinical Guidelines
  • Specific Medications
  • I. Buspirone
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Other Information
  • Effects Documented in Nonhuman Animals
  • Serotonin Antagonist/Reuptake Inhibitors (SARIs)
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Adverse Drug Interactions
  • Overdose
  • Clinical Guidelines
  • Specific Medications
  • I. Trazodone Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Other Information
  • Effects Documented in Nonhuman Animals
  • Note
  • References
  • Chapter 10 Anticonvulsants and Mood Stabilizers
  • Action
  • Overview of Indications
  • Clinical Guidelines
  • Specific Medications
  • I. Carbamazepine
  • Clinical Pharmacology
  • Side Effects
  • Effects in Non-human Animals
  • II. Gabapentin
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Other Information
  • Effects Documented in Non-human Animals
  • Cattle
  • III. Pregabalin
  • Clinical Pharmacology
  • Uses in Humans
  • Side Effects
  • Effects Documented in Nonhuman Animals
  • References
  • Chapter 11 Sympatholytic Agents
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Overdose
  • Clinical Guidelines (Table 11.1)
  • Specific Medications
  • I. Clonidine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Other Information
  • Effects Documented in Nonhuman Animals
  • II. Detomidine
  • Clinical Pharmacology
  • Use in Humans
  • Contraindications
  • Side Effects
  • Other Information
  • Effects Documented in Nonhuman Animals
  • III. Dexmedetomidine
  • Clinical Pharmacology
  • Use in Humans
  • Contraindications
  • Side Effects
  • Effects Documented in Nonhuman Animals
  • IV. Propranolol
  • Clinical Pharmacology
  • Use in Humans
  • Contraindications
  • Side Effects
  • Effects Documented in Nonhuman Animals
  • References
  • Chapter 12 N-Methyl-D-Aspartate (NMDA) Receptor Antagonists
  • Action
  • Overview of Indications
  • Contraindications/Side Effects, and Adverse Events
  • Clinical Guidelines
  • Specific Medications
  • I. Dextromethorphan
  • Clinical Pharmacology
  • Contraindications and Side Effects
  • Other Information
  • Effects Documented in Nonhuman Animals
  • Horses
  • II. Amantadine
  • Clinical Pharmacology
  • Use in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Effects Documented in Nonhuman Animals
  • III. Memantine
  • Clinical Pharmacology
  • Use in Humans
  • Side Effects
  • Other Information
  • Effects Documented in Nonhuman Animals
  • IV. Huperzine A
  • Clinical Pharmacology
  • Use in Humans
  • Overdose and Side Effects
  • Effects Documented in Nonhuman Animals
  • References
  • Chapter 13 Monoamine Oxidase Inhibitors
  • Action
  • Overview of Indications
  • Specific Medications
  • I. Selegiline Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • References
  • Chapter 14 Antipsychotics
  • Introduction
  • Action
  • Overview of Indications
  • General Pharmacokinetics
  • Contraindications, Side Effects, and Adverse Events
  • Overdose
  • Clinical Guidelines
  • Specific Medications
  • I. Acepromazine Maleate
  • Clinical Pharmacology
  • Indications
  • Contraindications
  • Side Effects
  • Adverse Drug Interactions
  • Overdose
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • II. Azaperone
  • Clinical Pharmacology
  • Indications
  • Doses in Nonhuman Animals
  • III. Chlorpromazine
  • Clinical Pharmacology
  • Uses in Humans
  • Indications in Veterinary Medicine
  • Contraindications
  • Side Effects
  • Effects Documented in Nonhuman Animals
  • IV. Clozapine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • V. Fluphenazine
  • Clinical Pharmacology
  • Contraindications and Side Effects
  • Effects Documented in Nonhuman Animals
  • VI. Haloperidol
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • VII. Pimozide
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • VIII. Promazine
  • Clinical Pharmacology
  • Indications
  • Contraindications
  • Side Effects
  • IX. Sulpiride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • X. Thioridazine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • Important Information for Owners of Pets Being Placed on an Antipsychotic
  • References
  • Chapter 15 CNS Stimulants
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Adverse Drug Interactions
  • Overdose
  • Clinical Guidelines
  • Specific Medications
  • I. Amphetamine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • Other Species
  • II. Atomoxetine HCl
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • III. Methylphenidate Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • Important Information for Owners of Pets Being Placed on CNS Stimulants
  • Clinical Examples
  • Case 1
  • Signalment
  • Presenting Complaint
  • History
  • Diagnosis
  • Treatment Plan
  • Follow-Up
  • References
  • Chapter 16 Tricyclic Antidepressants
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Adverse Drug Interactions
  • Overdose
  • Discontinuation
  • Clinical Guidelines
  • Specific Medications
  • I. Amitriptyline
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • II. Clomipramine Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation
  • Effects Documented in Nonhuman Animals
  • III. Desipramine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Effects Documented in Nonhuman Animals
  • IV. Doxepin
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Effects Documented in Nonhuman Animals
  • V. Imipramine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Effects Documented in Nonhuman Animals
  • VI. Nortriptyline
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Effects Documented in Nonhuman Animals
  • Important Information for Owners of Pets Being Placed on any TCA
  • References
  • Chapter 17 Opioids and Opioid Antagonists
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Clinical Guidelines
  • Specific Medications
  • I. Nalmefene
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Other Information
  • Effects Documented in Nonhuman Animals
  • II. Naloxone HCl
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Doses in Nonhuman Animals
  • Discontinuation
  • Effects Documented in Nonhuman Animals
  • III. Naltrexone Hydrochloride
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation
  • Other Information
  • Uses Documented in Nonhuman Animals
  • IV. Pentazocine
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Overdose
  • Discontinuation
  • Other Information
  • Effects Documented in Nonhuman Animals
  • References
  • Chapter 18 Hormones
  • Introduction
  • Oxytocin
  • Clinical Pharmacology
  • Indications
  • Side Effects
  • Doses in Nonhuman Animals
  • Effects Documented in Nonhuman Animals
  • Progestins
  • Action
  • Overview of Indications
  • Contraindications, Side Effects, and Adverse Events
  • Overdose
  • Clinical Guidelines
  • Specific Medications
  • I. Medroxyprogesterone Acetate (MPA)
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Side Effects
  • Adverse Drug Interactions
  • Effects Documented in Nonhuman Animals
  • II. Megestrol Acetate
  • Clinical Pharmacology
  • Uses in Humans
  • Contraindications
  • Adverse Drug Interactions
  • Side Effects
  • Overdose
  • Effects Documented in Nonhuman Animals
  • References
  • Chapter 19 Combinations
  • Introduction
  • Overview of Drug Augmentation
  • Potentially Beneficial Combinations
  • Adverse Interactions and Contraindications
  • Changing and Weaning Patients off Medications
  • Cytochrome P450 (CYP)
  • Interactions That Can Affect Dosing
  • Algorithms: Possible Future Direction
  • Conclusion
  • References
  • Index
  • EULA

Dateiformat: PDF
Kopierschutz: Adobe-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).

Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions (siehe E-Book Hilfe).

E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Mit Adobe-DRM wird hier ein "harter" Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Bitte beachten Sie bei der Verwendung der Lese-Software Adobe Digital Editions: wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!

Weitere Informationen finden Sie in unserer E-Book Hilfe.


Download (sofort verfügbar)

109,99 €
inkl. 7% MwSt.
Download / Einzel-Lizenz
PDF mit Adobe-DRM
siehe Systemvoraussetzungen
E-Book bestellen